J R Corvalán - Concepedia

Author

J R Corvalán

Also Known As

J Corválan, J R Corvalan, J R Corvalán, J. R. F. CORVALÁN, J. R. F. Corvalan, J. R. F. Corvalán, J.R.F. CORVALAN, J.R.F. Corvalan, JRF Corvalan

Publications

994

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Eli Lilly (Japan)

About

J R Corvalán is an author at Eli Lilly (United States) specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	922
2	Immunology	9	9	885
3	Cell Biology	4	4	486
4	Allergy	1	1	44
5	Biochemistry	1	1	33

J R Corvalán

Publications

934

Citations

H-Index

Page 1

	Year	Citations
Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy. Xiaodong Yang, Xiao‐Chi Jia, J R Corvalán, PubMed ImmunologyGrowth Factor AlphaImmunotherapyCancer BiologyTumor Biology	1999	330
Use of monoclonal antibodies for the histopathological diagnosis of human malignancy KC Gatter, Z. Abdulaziz, Peter C. L. Beverley, Journal of Clinical Pathology Histopathological DiagnosisAntibody PanelImmunologyPathologyImmunophenotyping	1982	222
Antitumor properties of vindesine-monoclonal antibody conjugates G. F. Rowland, C.A. Axton, R W Baldwin, Cancer Immunology Immunotherapy Vindesine-monoclonal Antibody ConjugatesImmunologyAntibody EngineeringTumor TargetingAnti-cancer Agent	1985	76
Production of an H–2-related suppressor factor by a hybrid T-cell line Michael Taussig, J R Corvalán, R M Binns, Nature Signal TransductionCell RegulationH–2-related Suppressor FactorImmune RegulationImmunology	1979	75
Construction and characterisation of a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids J R Corvalán, William K. Smith Cancer Immunology Immunotherapy Vinca AlkaloidsHybrid-hybrid Monoclonal AntibodyMedicineImmunologyPathology	1987	45
Immune response genes controlling responsiveness to major transplantation antigens. Specific major histocompatibility complex-linked defect for antibody responses to class I alloantigens. Geoffrey W. Butcher, J R Corvalán, D Licence, The Journal of Experimental Medicine HistocompatibilityImmune ToleranceGeneticsImmunologyAntigen Processing	1982	44
Specific in vitro and in vivo drug localisation to tumour cells using a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids J R Corvalán, William K. Smith, Vivek Gore, Cancer Immunology Immunotherapy Immunocytochemical TechniqueOncologyVinca AlkaloidsMalignant DiseaseHybrid-hybrid Monoclonal Antibody	1987	37
Increased therapeutic effect of vinca alkaloids targeted to tumour by a hybrid-hybrid monoclonal antibody J R Corvalán, William K. Smith, Vivek Gore, Cancer Immunology Immunotherapy OncologyVinca AlkaloidsTherapeutic EffectHybrid-hybrid Monoclonal AntibodyMedicine	1987	33
Defective monocyte accessory function due to surface sulphydryl (SH) oxidation in rheumatoid arthritis. Micheál McKeown, N. D. Hall, J R Corvalán PubMed ImmunologyImmunotherapyRedox BiologyInflammatory ArthritisOxidative Stress	1984	33
Tumour therapy with vinca alkaloids targeted by a hybrid-hybrid monoclonal antibody recognising both CEA and vinca alkaloids J R Corvalán, William K. Smith, Vivek Gore International Journal of Cancer Tumor BiologyOncologyVinca AlkaloidsHybrid-hybrid Monoclonal AntibodyMedicine	1988	27

Page 1